These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

496 related items for PubMed ID: 9329453

  • 1. Molecular genetic evidence for subtypes of oligoastrocytomas.
    Maintz D, Fiedler K, Koopmann J, Rollbrocker B, Nechev S, Lenartz D, Stangl AP, Louis DN, Schramm J, Wiestler OD, von Deimling A.
    J Neuropathol Exp Neurol; 1997 Oct; 56(10):1098-104. PubMed ID: 9329453
    [Abstract] [Full Text] [Related]

  • 2. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M.
    Clin Cancer Res; 2005 Feb 01; 11(3):1119-28. PubMed ID: 15709179
    [Abstract] [Full Text] [Related]

  • 3. Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma.
    Kraus JA, Koopmann J, Kaskel P, Maintz D, Brandner S, Schramm J, Louis DN, Wiestler OD, von Deimling A.
    J Neuropathol Exp Neurol; 1995 Jan 01; 54(1):91-5. PubMed ID: 7815084
    [Abstract] [Full Text] [Related]

  • 4. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.
    Ueki K, Nishikawa R, Nakazato Y, Hirose T, Hirato J, Funada N, Fujimaki T, Hojo S, Kubo O, Ide T, Usui M, Ochiai C, Ito S, Takahashi H, Mukasa A, Asai A, Kirino T.
    Clin Cancer Res; 2002 Jan 01; 8(1):196-201. PubMed ID: 11801559
    [Abstract] [Full Text] [Related]

  • 5. Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas.
    Watanabe T, Nakamura M, Kros JM, Burkhard C, Yonekawa Y, Kleihues P, Ohgaki H.
    Acta Neuropathol; 2002 Mar 01; 103(3):267-75. PubMed ID: 11907807
    [Abstract] [Full Text] [Related]

  • 6. Genetically distinct astrocytic and oligodendroglial components in oligoastrocytomas.
    Qu M, Olofsson T, Sigurdardottir S, You C, Kalimo H, Nistér M, Smits A, Ren ZP.
    Acta Neuropathol; 2007 Feb 01; 113(2):129-36. PubMed ID: 17031656
    [Abstract] [Full Text] [Related]

  • 7. Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas.
    von Deimling A, Louis DN, von Ammon K, Petersen I, Wiestler OD, Seizinger BR.
    Cancer Res; 1992 Aug 01; 52(15):4277-9. PubMed ID: 1353411
    [Abstract] [Full Text] [Related]

  • 8. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p.
    Reifenberger J, Reifenberger G, Liu L, James CD, Wechsler W, Collins VP.
    Am J Pathol; 1994 Nov 01; 145(5):1175-90. PubMed ID: 7977648
    [Abstract] [Full Text] [Related]

  • 9. Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization.
    Bigner SH, Matthews MR, Rasheed BK, Wiltshire RN, Friedman HS, Friedman AH, Stenzel TT, Dawes DM, McLendon RE, Bigner DD.
    Am J Pathol; 1999 Aug 01; 155(2):375-86. PubMed ID: 10433931
    [Abstract] [Full Text] [Related]

  • 10. Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets.
    Mueller W, Hartmann C, Hoffmann A, Lanksch W, Kiwit J, Tonn J, Veelken J, Schramm J, Weller M, Wiestler OD, Louis DN, von Deimling A.
    Am J Pathol; 2002 Jul 01; 161(1):313-9. PubMed ID: 12107116
    [Abstract] [Full Text] [Related]

  • 11. CIC and FUBP1 mutations in oligodendrogliomas, oligoastrocytomas and astrocytomas.
    Sahm F, Koelsche C, Meyer J, Pusch S, Lindenberg K, Mueller W, Herold-Mende C, von Deimling A, Hartmann C.
    Acta Neuropathol; 2012 Jun 01; 123(6):853-60. PubMed ID: 22588899
    [Abstract] [Full Text] [Related]

  • 12. [Correlation between loss of heterozygosity on chromosome 1p and 19q and expression of MGMT, p53 and Ki-67 proteins in gliomas].
    Huang L, Jiang T, Yuan F, Li GL, Xu LX, Cui Y.
    Zhonghua Zhong Liu Za Zhi; 2011 Oct 01; 33(10):752-8. PubMed ID: 22335907
    [Abstract] [Full Text] [Related]

  • 13. Correlation of chromosomes 1p and 19q status and expressions of O6-methylguanine DNA methyltransferase (MGMT), p53 and Ki-67 in diffuse gliomas of World Health Organization (WHO) grades II and III: a clinicopathological study.
    Huang L, Jiang T, Yuan F, Li GL, Cui Y, Liu EZ, Wang ZC.
    Neuropathol Appl Neurobiol; 2009 Aug 01; 35(4):367-379. PubMed ID: 19019173
    [Abstract] [Full Text] [Related]

  • 14. Assessment of 1p/19q status by fluorescence in situ hybridization assay: A comparative study in oligodendroglial, mixed oligoastrocytic and astrocytic tumors.
    Shukla B, Agarwal S, Suri V, Pathak P, Sharma MC, Gupta D, Sharma BS, Suri A, Halder A, Sarkar C.
    Neurol India; 2009 Aug 01; 57(5):559-66. PubMed ID: 19934553
    [Abstract] [Full Text] [Related]

  • 15. Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas.
    Okamoto Y, Di Patre PL, Burkhard C, Horstmann S, Jourde B, Fahey M, Schüler D, Probst-Hensch NM, Yasargil MG, Yonekawa Y, Lütolf UM, Kleihues P, Ohgaki H.
    Acta Neuropathol; 2004 Jul 01; 108(1):49-56. PubMed ID: 15118874
    [Abstract] [Full Text] [Related]

  • 16. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas.
    Ohgaki H, Kleihues P.
    J Neuropathol Exp Neurol; 2005 Jun 01; 64(6):479-89. PubMed ID: 15977639
    [Abstract] [Full Text] [Related]

  • 17. Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma.
    Sahm F, Reuss D, Koelsche C, Capper D, Schittenhelm J, Heim S, Jones DT, Pfister SM, Herold-Mende C, Wick W, Mueller W, Hartmann C, Paulus W, von Deimling A.
    Acta Neuropathol; 2014 Oct 01; 128(4):551-9. PubMed ID: 25143301
    [Abstract] [Full Text] [Related]

  • 18. Novel molecular stereotactic biopsy procedures reveal intratumoral homogeneity of loss of heterozygosity of 1p/19q and TP53 mutations in World Health Organization grade II gliomas.
    Thon N, Eigenbrod S, Grasbon-Frodl EM, Ruiter M, Mehrkens JH, Kreth S, Tonn JC, Kretzschmar HA, Kreth FW.
    J Neuropathol Exp Neurol; 2009 Nov 01; 68(11):1219-28. PubMed ID: 19816195
    [Abstract] [Full Text] [Related]

  • 19. Loss of 14q chromosome in oligodendroglial and astrocytic tumors.
    Dichamp C, Taillibert S, Aguirre-Cruz L, Lejeune J, Marie Y, Kujas M, Delattre JY, Hoang-Xuan K, Sanson M.
    J Neurooncol; 2004 May 01; 67(3):281-5. PubMed ID: 15164983
    [Abstract] [Full Text] [Related]

  • 20. Allelic losses in oligodendroglial and oligodendroglioma-like neoplasms: analysis using microsatellite repeats and polymerase chain reaction.
    Johnson MD, Vnencak-Jones CL, Toms SA, Moots PM, Weil R.
    Arch Pathol Lab Med; 2003 Dec 01; 127(12):1573-9. PubMed ID: 14632576
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.